Skip to main content
. Author manuscript; available in PMC: 2017 Nov 15.
Published in final edited form as: Immunity. 2016 Oct 25;45(5):1052–1065. doi: 10.1016/j.immuni.2016.10.005

Figure 3. Regulation of the AM14 Response by cDCs Requires Fas.

Figure 3

(A) Experiment design. 8-9 × 106 Fas-sufficient AM14.MRL.Faslpr/+ B cells were transferred into Fas-sufficient MRL.Faslpr/+ recipients that either lacked cDCs (ΔDC) or into littermate controls (Cntrl) on day 0. The AM14 B cell response was activated with PL2-3 on days 0, 2 and 4, or left untreated (no Ag). Some mice did not receive cell transfer or Ag (no Tfr). Spleens were harvested on day 6.

(B) Number of AM14 B cells (4-44+) per spleen.

(C) Number of AM14 plasmablasts (4-44+, CD22lo, CD44hi) per spleen.

(D, E, & F) ELISpot assays for the number of 4-44+, IgM+, IgG2a+, or IgG2b+ AFCs per spleen. Data were combined from 5 experiments to obtain 15-29 mice per group receiving PL2-3 and 2-7 mice in the other groups. Bars represent mean and SEM. ****p < 0.0001 by Mann-Whitney U test.

(G) Immunofluorescence histology was performed on spleens from experimental mice. Images were taken at a magnification of 100x. Red, AM14 B cells (4-44+); green, B cell follicles (B220+); blue, T cell zones (CD4+). White scale bars are 200 μm. See also Figures S4 and S5.